Free Trial

Addus HomeCare (ADUS) Competitors

Addus HomeCare logo
$103.92 -0.63 (-0.60%)
Closing price 05/1/2025 04:00 PM Eastern
Extended Trading
$103.94 +0.02 (+0.02%)
As of 05/1/2025 06:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ADUS vs. HIMS, GH, OPCH, RDNT, SHC, WGS, BTSG, PRVA, CON, and SGRY

Should you be buying Addus HomeCare stock or one of its competitors? The main competitors of Addus HomeCare include Hims & Hers Health (HIMS), Guardant Health (GH), Option Care Health (OPCH), RadNet (RDNT), Sotera Health (SHC), GeneDx (WGS), BrightSpring Health Services (BTSG), Privia Health Group (PRVA), Concentra Group Holdings Parent (CON), and Surgery Partners (SGRY). These companies are all part of the "healthcare" industry.

Addus HomeCare vs.

Hims & Hers Health (NYSE:HIMS) and Addus HomeCare (NASDAQ:ADUS) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, media sentiment, earnings, community ranking and dividends.

Hims & Hers Health presently has a consensus price target of $36.92, suggesting a potential upside of 1.44%. Addus HomeCare has a consensus price target of $139.00, suggesting a potential upside of 33.76%. Given Addus HomeCare's stronger consensus rating and higher probable upside, analysts clearly believe Addus HomeCare is more favorable than Hims & Hers Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hims & Hers Health
2 Sell rating(s)
8 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.08
Addus HomeCare
0 Sell rating(s)
0 Hold rating(s)
7 Buy rating(s)
2 Strong Buy rating(s)
3.22

In the previous week, Hims & Hers Health had 48 more articles in the media than Addus HomeCare. MarketBeat recorded 55 mentions for Hims & Hers Health and 7 mentions for Addus HomeCare. Addus HomeCare's average media sentiment score of 1.39 beat Hims & Hers Health's score of 0.64 indicating that Addus HomeCare is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hims & Hers Health
25 Very Positive mention(s)
8 Positive mention(s)
12 Neutral mention(s)
3 Negative mention(s)
0 Very Negative mention(s)
Positive
Addus HomeCare
5 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

63.5% of Hims & Hers Health shares are held by institutional investors. Comparatively, 95.3% of Addus HomeCare shares are held by institutional investors. 17.7% of Hims & Hers Health shares are held by company insiders. Comparatively, 4.6% of Addus HomeCare shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Addus HomeCare has lower revenue, but higher earnings than Hims & Hers Health. Addus HomeCare is trading at a lower price-to-earnings ratio than Hims & Hers Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hims & Hers Health$1.48B5.48-$23.55M$0.5467.40
Addus HomeCare$1.15B1.64$62.52M$4.2424.51

Hims & Hers Health has a net margin of 8.19% compared to Addus HomeCare's net margin of 6.50%. Hims & Hers Health's return on equity of 10.97% beat Addus HomeCare's return on equity.

Company Net Margins Return on Equity Return on Assets
Hims & Hers Health8.19% 10.97% 8.29%
Addus HomeCare 6.50%9.62%7.37%

Hims & Hers Health has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500. Comparatively, Addus HomeCare has a beta of 0.93, suggesting that its stock price is 7% less volatile than the S&P 500.

Addus HomeCare received 288 more outperform votes than Hims & Hers Health when rated by MarketBeat users. Likewise, 68.96% of users gave Addus HomeCare an outperform vote while only 35.25% of users gave Hims & Hers Health an outperform vote.

CompanyUnderperformOutperform
Hims & Hers HealthOutperform Votes
43
35.25%
Underperform Votes
79
64.75%
Addus HomeCareOutperform Votes
331
68.96%
Underperform Votes
149
31.04%

Summary

Addus HomeCare beats Hims & Hers Health on 10 of the 19 factors compared between the two stocks.

Get Addus HomeCare News Delivered to You Automatically

Sign up to receive the latest news and ratings for ADUS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ADUS vs. The Competition

MetricAddus HomeCareHome health care services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.89B$3.03B$5.53B$7.93B
Dividend YieldN/A0.35%5.11%4.22%
P/E Ratio23.7829.3922.5118.54
Price / Sales1.641.10397.62103.30
Price / Cash21.6517.2938.1834.62
Price / Book2.383.366.734.25
Net Income$62.52M-$57.02M$3.22B$248.18M
7 Day Performance3.32%1.39%1.38%1.03%
1 Month Performance4.04%-7.72%2.79%2.70%
1 Year Performance5.60%17.46%15.41%4.05%

Addus HomeCare Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ADUS
Addus HomeCare
4.7016 of 5 stars
$103.92
-0.6%
$139.00
+33.8%
+5.6%$1.89B$1.15B23.7833,200Upcoming Earnings
Positive News
HIMS
Hims & Hers Health
2.3614 of 5 stars
$28.51
+1.5%
$38.08
+33.6%
+191.3%$6.33B$1.48B64.80650Upcoming Earnings
Analyst Forecast
Insider Trade
Options Volume
News Coverage
High Trading Volume
GH
Guardant Health
3.946 of 5 stars
$47.99
-0.6%
$49.00
+2.1%
+167.6%$5.92B$739.02M-13.481,790Analyst Forecast
News Coverage
Gap Up
OPCH
Option Care Health
3.8017 of 5 stars
$32.97
+0.2%
$33.75
+2.4%
+7.3%$5.42B$5.00B27.715,600Earnings Report
Analyst Upgrade
News Coverage
Positive News
RDNT
RadNet
4.0149 of 5 stars
$51.03
+1.5%
$69.75
+36.7%
+3.5%$3.78B$1.83B-728.908,970Positive News
SHC
Sotera Health
2.3908 of 5 stars
$11.26
+0.9%
$15.20
+35.0%
+7.4%$3.20B$1.10B45.043,000News Coverage
Gap Up
WGS
GeneDx
3.7539 of 5 stars
$112.49
+1.3%
$72.33
-35.7%
+197.9%$3.16B$305.45M-57.391,200Earnings Report
Analyst Forecast
Insider Trade
News Coverage
Positive News
Gap Up
BTSG
BrightSpring Health Services
2.5503 of 5 stars
$17.31
+2.3%
$21.67
+25.2%
+67.9%$3.03B$11.27B-66.5835,000Upcoming Earnings
News Coverage
Positive News
PRVA
Privia Health Group
4.1082 of 5 stars
$23.20
+0.1%
$27.14
+17.0%
+27.0%$2.81B$1.74B232.02810Upcoming Earnings
Analyst Forecast
Short Interest ↓
News Coverage
Positive News
CON
Concentra Group Holdings Parent
N/A$21.64
+1.8%
$28.50
+31.7%
N/A$2.76B$1.90B14.3311,000Upcoming Earnings
Positive News
SGRY
Surgery Partners
3.2138 of 5 stars
$21.56
+0.4%
$34.75
+61.2%
-8.9%$2.75B$3.11B-44.9212,200News Coverage

Related Companies and Tools


This page (NASDAQ:ADUS) was last updated on 5/2/2025 by MarketBeat.com Staff
From Our Partners